Applications for medical devices under the Interim Order for use in relation to COVID-19: Guidance document
Date published: March 27, 2020
Last Updated: August 28, 2020
Guidance documents are meant to provide assistance to industry and health care professionals on how to comply with governing statutes and regulations. Guidance documents also provide assistance to staff on how Health Canada mandates and objectives should be implemented in a manner that is fair, consistent, and effective.
Guidance documents are administrative instruments not having force of law and, as such, allow for flexibility in approach. Alternate approaches to the principles and practices described in this document may be acceptable provided they are supported by adequate justification. Alternate approaches should be discussed in advance with the relevant programme area to avoid the possible finding that applicable statutory or regulatory requirements have not been met.
As a corollary to the above, it is equally important to note that Health Canada reserves the right to request information or material, or define conditions not specifically described in this document, in order to allow the Department to adequately assess the safety, efficacy, or quality of a therapeutic product. Health Canada is committed to ensuring that such requests are justifiable and that decisions are clearly documented.
This document should be read in conjunction with the accompanying notice and the relevant sections of other applicable Guidance documents.
Table of contents
- 1. Introduction
- 2. Guidance for implementation
- Authorization for Importation or Sale
- Fees related to the submission of an application for a COVID-19 medical device
- Quality Management System requirements related to the submission of an application for a COVID-19 medical device
- Submitting an application for a COVID-19 medical device
- Issuance of Authorization
- Submitting an amendment to a COVID-19 approval
- Terms and Conditions
- Additional Information and Material
- Incident Reporting
- Expanded Use
- Service standards
Health Canada has developed this guidance document in order to support the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 pursuant to subsection 30.1(1) of the Food and Drugs Act. This Interim Order will allow the Department to issue expedited authorization for sale or import of medical devices to deal with the current significant risk of COVID-19 to the health and safety of Canadians.
1.2 Scope and application
This guidance document is intended to provide guidance to manufacturers to organize and submit an application in a timely manner for the sale or importation of medical devices that are manufactured, sold or represented for use in relation to COVID-19. This includes a medical device that is part of a system, test kit, medical device group, medical device family or medical device group family as defined in the Medical Devices Regulations.
Devices that meet the definition of a COVID-19 medical device as defined in the Interim Order, must clearly indicate its direct use in relation to the SARS-CoV-2 virus, including the active role the device plays in the diagnosis, treatment, mitigation or prevention of COVID-19, the disease caused by the virus.
The guidance document also outlines manufacturers' responsibility to report incidents relating to COVID-19 medical devices to Health Canada, as soon as they become aware of them. It also provides information on what the responsibilities are of manufacturers of COVID-19 medical devices should they need to recall a device approved through this mechanism.
1.3 Policy objectives
To provide assistance to manufacturers in preparing the documentation necessary to obtain authorization for the sale or importation of a COVID-19 medical device under Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19.
1.4 Policy statements
Manufacturers are required to submit an application to Health Canada for the purpose of obtaining authorization to sell or import a COVID-19 medical device.
The Interim Order outlines Health Canada's expectation and the information that is required to obtain authorization to import and sell COVID-19 medical devices in Canada. Importantly, an authorization under this Interim Order will be granted only if Health Canada determines that there is a public health need for the importation or sale of the COVID-19 medical device submitted.
The Interim Order provides an expedited authorization pathway for
- new COVID-19-medical devices that are not yet licensed in Canada or other jurisdictions,
- COVID-19-related uses for existing devices licensed under the Medical Device Regulations, or under this Interim Order, and
- COVID-19 medical devices that leverage an authorization of a device from a trusted foreign regulatory authority, whereby the Minister would maintain the ability to request additional information on a case-by-case basis.
This expedited authorization for sale or import does not apply to medical device licenses which are currently suspended on the grounds of safety or effectiveness concerns. It is not intended to permit sale or import of previously licensed medical devices with identified safety or effectiveness concerns.
Note: The authorization for importation and sale is only valid for as long as the Interim Order is in effect, for a period of up to one year, unless it is renewed.
COVID-19 is the infectious disease caused by the most recently discovered coronavirus, SARS-CoV-2. This new virus and disease were unknown before the outbreak began in Wuhan, China, in December 2019. COVID-19 has been known to cause respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, COVID-19 infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Older people, and those with underlying medical problems like high blood pressure, heart problems or diabetes, are more likely to develop serious illness.
On March 11, 2020, the World Health Organization (WHO) declared a global pandemic related to COVID-19. Most people recover from the disease without needing special treatment, however, it appears that around 1 out of every 6 people who gets COVID-19 becomes seriously ill and develops difficulty breathing.
The Interim Order and this guidance document have been developed to ensure that medical devices that are integral to the diagnosis, treatment, mitigation or prevention of COVID-19 can be quickly authorized for sale or importation in order to address the urgent public health need.
2. Guidance for implementation
COVID-19 medical device
Means a medical device that is manufactured, sold or represented for use in relation to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
A unique series of letters, numbers or symbols, or any combination of these, that is assigned to a medical device by the manufacturer and from which a history of the manufacture, packaging, labelling and distribution of a unit, lot or batch of the device can be determined.
Foreign regulatory authority
A government agency or other entity outside Canada that has a legal right to control the manufacturing, use or sale of medical devices within its jurisdiction and that may take enforcement action to ensure that medical devices marketed within its jurisdiction comply with the applicable legal requirements.
Any incident involving a COVID-19 medical device that
- is related to a failure of the device or a deterioration in its quality or effectiveness, or any inadequacy in its labelling or in its directions for use; or
- has led to the death or a serious deterioration in the state of health of a patient, user or other person, or could do so were it to recur.
In Vitro Diagnostic Device (IVDD)
A medical device that is intended to be used in vitro for the examination of specimens taken from the body.
List of Medical Devices for Expanded Use
The List of Medical Devices for Expanded Use in Relation to the COVID-19 Pandemic that is published by the Government of Canada on its website, as amended from time to time.
A person who sells a medical device under their own name, or under a trademark, design, trade name or other name or mark owned or controlled by the person, and who is responsible for designing, manufacturing, assembling, processing, labelling, packaging, refurbishing or modifying the device, or for assigning to it a purpose, whether those tasks are performed by that person or on their behalf.
A device within the meaning of the Food and Drugs Act, but does not include any device that is intended for use in relation to animals.
Medical device family
A group of medical devices that are made by the same manufacturer, that differ only in shape, colour, flavour or size, that have the same design and manufacturing process and that have the same intended use.
Medical device group
A medical device comprising a collection of medical devices, such as a procedure pack or tray, that is sold under a single name.
Medical device group family
A collection of medical device groups that are made by the same manufacturer, that have the same generic name specifying their intended use, and that differ only in the number and combination of products that comprise each group.
Name of the device
In respect of a medical device, includes any information necessary for the user to identify the device and to distinguish it from similar devices.
In respect of a medical device that has been sold, means any action taken by the manufacturer, importer or distributor of the device to recall or correct the device, or to notify its owners and users of its defectiveness or potential defectiveness, after becoming aware that the device:
- may be hazardous to health, or
- may fail to conform to any claim made by the manufacturer or importer relating to its effectiveness, benefits, performance characteristics or safety
A medical device comprising a number of components or parts intended to be used together to fulfill some or all of the device's intended functions, and that is sold under a single name.
An in vitro diagnostic device that consists of reagents or articles, or any combination of these, and that is intended to be used to conduct a specific test.
Refers to the Medical Devices Regulations.
Authorization for Importation or Sale
The Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 provides COVID-19 medical device manufacturers an exemption from the requirements under Part 1 of the Medical Devices Regulations, provided they have received an authorization for the importation or sale from Health Canada.
When Health Canada determines that there is an urgent public health need for the importation or sale of a COVID-19 medical device, the manufacturer may submit an application for authorization under the Interim Order (Appendix A). For traceability purposes, Health Canada is issuing the authorization to manufacturers of COVID-19 medical devices, not to importers or distributors. If an authorization is granted, the manufacturer may import or sell their COVID-19 device in Canada. The manufacturer's information and device information on the device label can then be cross-referenced against the authorization during importation and distribution, along with the letter of authorization that is required to accompany the product during import. The Minister may also decide to issue an expanded indication for use to a device that has either been approved through this Interim Order, or a device that was granted a Medical Device Licence. The authorization for importation or sale is only valid for as long as the Interim Order is in effect. The Interim Order will expire one-year after it came into effect, but may be subject to renewal based on the ongoing public health need.
Fees related to the submission of an application for a COVID-19 medical device
To remove impediments for manufacturers in this time of public health need, Health Canada will waive all application fees for COVID-19 medical devices subject to the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19.
Quality Management System requirements related to the submission of an application for a COVID-19 medical device
To remove impediments for manufacturers in this time of public health need, Health Canada does not require manufacturers to provide a MDSAP certificate with their application for a COVID-19 medical device subject to the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19. Manufacturers will be required to share information to demonstrate that their products are of consistent quality and effectiveness. This can be demonstrated by either providing a copy of the manufacturer's Quality Management System certificate to ISO 13485:2016, or by submitting evidence of Good Manufacturing Practices.
In the absence of a valid ISO 13485:2016 certificate, information supporting the following criteria, as a minimum, should be included in an application for a COVID-19 medical device:
A documented process for controlling design and development. The process should include:
- Relevant planning stages;
- Identification of design inputs and product and performance requirements;
- Risk management activities associated with the device and its use;
- Identification, review, and approval of design outputs;
- Validation of design;
- Control of design changes (including review and approval); and
- Design transfer into production.
Relevant records of approved design outputs, risk management, and design validation should be included where available (e.g. Design History File (DHF)).
Evidence of adequate quality planning, including but not limited to:
- Final approved specification for the product and all components, including labelling, Instructions for Use (IFU), packaging, etc. (e.g. Device Master File (DMF));
- Complete manufacturing/production process;
- Implementation of risk mitigation measures in manufacturing/production;
- Complete test and acceptance activities, including pass/fail criteria, for product and all components;
- Validation of test and inspection methods, including statistical rationale as appropriate;
- Specifications for infrastructure (e.g. controlled environments, water for injection (WFI)/deionized water (DIW), refrigerated storage, biocontrol hoods, material flow, etc.);
- Identification of retained samples required to assist stability studies and post-market investigations;
- Competence/training requirements, as necessary; and
- Process validation requirements (e.g. master validation plan).
Evidence of adequate purchasing controls, including but not limited to:
- Approved specifications for purchased components, products, and services;
- Acceptance criteria and planned verification of purchased components, products, and services;
- Documented process and procedures for evaluation and qualification of suppliers; and
- Evidence of supplier evaluation and qualification.
Documented procedures and work instructions for:
- All manufacturing activities;
- All in-process inspections and tests;
- Maintaining traceability, including results of tests and inspections and environmental conditions as necessary (e.g. preparation of Device Master Record (DMR));
- Identification of product status (e.g. in-process, under review, nonconforming, released, etc.)
- Final review of production records and final product release;
- Identification and calibration of test equipment, fixtures, jigs, etc.;
- Inventory control;
- Service and installation activities (as required); and
- Handling, storage, and distribution including record keeping.
Corrective Actions and Post-Market Activities
Documented procedures and work instructions (as appropriate) for:
- Identification, analysis, and monitoring or data sources to identify nonconformities or potential nonconformities;
- Handling/disposition of in-process nonconformities (e.g. Material Review Board (MRB), Out of Spec (OOS) procedure, etc.);
- Receiving, evaluating, and investigating feedback (i.e., complaints handling);
- Detecting, evaluating, and investigating nonconformities;
- Corrections and actions to prevent the recurrence of nonconformities including verification of effectiveness;
- Reporting adverse events to Health Canada (i.e., mandatory problem reporting); and
- Conducting and reporting advisory notices, corrections, and removals to Health Canada (i.e. recall procedures).
Submitting an application for a COVID-19 medical device
An application for medical devices manufactured, sold or represented for use in relation to COVID-19 shall contain sufficient information and material for the Minister to render a decision whether or not to issue a COVID-19 medical device authorization, on the basis of the issuance criteria in s.5 of the Interim Order. This information is highlighted in section 4 of the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19.
This information can be submitted electronically, in whatever manner the applicant chooses. Applicants are welcome to use standard document submission guidelines (i.e., the ToC format), or provide a "question and answer" style of application, using the criteria specified below as headers. An application form has also been developed to facilitate the application process. The use of the application form is optional but is highly recommended to help ensure applicants have submitted the necessary information. Applications should be submitted to the following email address:
firstname.lastname@example.org with the subject line: COVID IO Submission.
Important: Please ensure that the application has been signed by a senior official of the manufacturer
An importer or distributor can act as a regulatory contact or regulatory representative on behalf of a manufacturer of a COVID-19 medical device. If this is the case, Health Canada expects the authorized regulatory representative(s) or contact(s) to be listed under section 4 of the application form. Importers and distributors can send complete Interim Order applications to Health Canada on behalf of a manufacturer of a COVID-19 medical device and can facilitate communication by providing additional information and material that is requested when processing an application.
Clarification on the specifics of the information required in an application filed in accordance with the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 is provided below.
Name of the Device
4(1)(a) of the Interim Order requires including the name of the device. This is the name that appears on the labelling proper and for which the authorization shall be issued under the Order. It includes any information necessary for the user to identify the device and to distinguish it from similar devices. In order to prevent duplication, multiple submissions for the same product should not be filed with Health Canada.
Class of the Device
4(1)(b) of the Interim Order must specify the class of the device. This is the classification that is attributed to the device according to the rules set out in Schedule 1 of the Medical Devices Regulations. According to the classification scheme, Class I represents the lowest risk and Class IV represents the highest risk. For this purposes of submitting an application under the Interim Order, a COVID-19 medical device can be classified into more than one class, the class representing the higher risk applies.
Identifier of the Device
4(1)(c) of the Interim Order requires the identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family be provided. For greater certainty, the definitions of each of these instances have been included above (see "Definitions").
4(1)(d) and 4(1)(e) of the Interim Order requires the submission of the name and address of the manufacturer as it appears on the device label, including the address where the device is manufactured (if different). For greater certainty, this should be listed as the legal manufacturer of the device.
Intended use of the device
4(1)(f) of the Interim Order requires the submission include information related to the diagnosis, treatment, mitigation, or prevention for which the COVID-19 medical device be provided. This information is crucial in establishing an understanding of the device and the device classification. The following information should be included in this section:
- intended purpose, mechanism of action, indications for use, conditions for which the device is used (the intended use statement should be verbatim as it appears on the device labelling);
- patient population for which the device is intended including age range, if applicable, and specific diagnoses;
- anatomical and physiological particulars related to the patient using the device, if applicable;
- whether or not the device uses an energy source and whether energy is transferred to the patient;
- the document version number and the date where the formal intended use appears.
Quality, Safety and Effectiveness information
4(1)(g) of the Interim Order requests that the applicant provide the known information in relation to the quality, safety and effectiveness of the device. To clarify the type of information that should be submitted, the following non-exhaustive list is provided as a guide to inform a submission. The Minister, under section 9 of the Interim Order, may request any additional information, if the information provided is deemed insufficient to render a decision whether to grant an authorization under this Interim Order.
- A clear description of the device, including how it works, any accessories to be used with it, and diagrams/photos of the device;
- A copy of the manufacturer's Quality Manufacturing System Certificate, evidence of Good Manufacturing Practices, or other;
- A discussion of whether any components are manufactured using additive manufacturing (3D printing, laser sintering, bioprinting, etc.);
- If this device is manufactured from or incorporates animal or human tissue or their derivative, evidence of biological safety of the device;
- A summary of any mechanical/bench testing data performed for the device;
- A summary of any animal testing and clinical investigations carried out with the device;
- A summary of any biocompatibility testing performed with the device (if applicable);
- A summary of the evidence of shelf-life and packaging validation testing (if applicable);
- A summary of electrical safety and electromagnetic compatibility (EMC) testing (if applicable);
- If the device is intended to be used at point of care or sold directly to a consumer, marketing materials for the device;
- If the device is intended to be sold in a sterile condition, a description of the sterilization method and a summary of sterilization validation testing performed;
- A list of applicable standards used in the design/manufacture of the device;
- Incidents with a discussion of each event and response from the manufacturer;
- A comparison table outlining technological differences between this device and predecessors that are or were licensed in Canada (if applicable);
- A comparison table outlining technological differences between the proposed COVID-19 medical device and any available (authorized) comparators, to the applicant's knowledge
- If the COVID-19 medical device is, or includes software, a discussion of the software validation testing performed;
- If the COVID-19 medical device is, or includes an in-vitro diagnostic device, analytical validation studies including but not limited to, specimen validation testing, sample preparation validation, the limit of detection, when applicable, inclusivity, cross reactivity (in silico analysis and cross reactivity testing), preliminary precision results (if applicable), stability of samples, preliminary reagent stability and clinical validity studies.
If the applicant has questions specific to the type of quality, safety and effectiveness information, they are urged to contact the Medical Devices Directorate, using the following email address:
Directions for Use
4(1)(h) of the Interim Order requests that the applicant provide the directions for use, unless directions are not required for the device to be used safely and effectively. This is the information supplied to the lay person and/or the health care professional enabling them to use the device without causing unnecessary harm to themselves or another person and to achieve the desired result. The Directions for Use should be written at a level commensurate with the training of the expected users.
For some complex, active or powered devices, the Directions for Use may require a special Surgeon's Instruction Manual, Operator's Manual, and a User's Manual.
All documents should have a control or version number clearly indicated in the document.
Attestation for Post-Market Oversight
4(1)(i) of the Interim Order requires the applicant to provide an attestation that documented procedures are in place in respect of distribution records, complaint handling, incident reporting and recalls. Appendix B provides an example of what Health Canada would look for in an attestation from an applicant (this information is also directly included in the COVID-19 application form for authorization of importation or sale of medical devices).
4(1)(i) of the Interim Order requires the applicant to provide an attestation that documented procedures are in place in respect of distribution records, complaint handling, incident reporting and recalls. Appendix B provides an example of what Health Canada would look for in an attestation from an applicant (this information is also directly included in the application form in Appendix A).
4(2)(a) of the Interim Order requires that, for Class III and IV COVID-19 medical devices, the applicant provides a description of the materials used in the manufacture and packaging of the device. Additionally, if there are any materials that are patient contacting for any period of time, biocompatibility testing of those materials may be required in order to render a decision on whether the Minister may issue an authorization.
4(2)(b) of the Interim Order requires that, for Class III and IV COVID-19 medical devices, the applicant provides a list of countries other than Canada where the device has been sold, the total number of units sold in those countries, and a summary of any reported problems with the device and any recalls of the device in those countries. This information can be provided in any format, however, summary tables are preferred.
Foreign Regulatory Approval
4(3) of the Interim Order stipulates that an applicant may omit the information required to be submitted in their initial application, specifically, items 4(1)(g), 4(2)(a) and 4(2)(b), if they provide evidence that their COVID-19 medical device has gained market approval by a foreign regulatory authority. This approval need not be at the National level, as Health Canada may accept approval at the State level. This evidence should include a copy of the formal approval letter issued by the authority, as well as any review summaries authored by the authority. For absolute certainty, if the Minister deems that the evidence of approval by a foreign authority is insufficient to ensure that section 5 of the Interim Order is met, the Minister may request additional information under section 9 of the Interim Order, and may also decide to issue an authorization with terms and conditions under section 7.
If a foreign jurisdiction waives all pre-market submission and evaluation requirements, this would not be considered a foreign regulatory approval for the purposes of the Interim Order.
Issuance of Authorization
For Health Canada to grant authorization for importation or sale of the COVID-19 medical device, all of the following conditions must be met:
- An application is submitted to Health Canada in accordance with subsection 4(1) and if applicable subsection 4(2) of the Interim Order;
- All additional requested information and material (including samples) is submitted to Health Canada upon request;
- Health Canada has assessed the submitted information and has concluded that the applicant provided sufficient evidence to support the benefits of the COVID-19 medical device and that the benefits of the COVID-19 medical device outweighs the risks associated with it. This takes into consideration the uncertainties related to the device in the context of an urgent public health need; and
- Health Canada determines that the health or safety of patients, users or any other person will not be unduly affected.
Health Canada publishes and maintains a list of testing devices that have been authorized for use against coronavirus as well as a list medical devices, other than testing devices, that have been authorized for sale or import in Canada under the Interim Order on its website.
Submitting an amendment to a COVID-19 approval
Section 6 of the Interim Order states that no person can import or sell a COVID-19 medical device if there are significant differences in the device from that which was initially submitted to Health Canada for approval under the Interim Order, unless the Minister has issued an amended authorization. These changes apply to any information submitted to the Minister under section 4 of this Interim Order, or as a response to a request for additional information under section 9.
The onus is on the authorization holder (i.e., the manufacturer) to identify and communicate these significant differences to Health Canada. It is recommended that a summary of the changes, compared to that which was initially approved, is submitted to Health Canada in electronic format using the following email address:
Terms and Conditions
Due to the nature of the application and issuance of expedited authorization to deal with the significant public health risk of COVID-19, Health Canada may, at any time, impose terms and conditions on the authorization for importation or sale of COVID-19 medical devices, or amend them.
As per above, Health Canada may cancel the authorization for importation or sale under the following conditions if:
- Health Canada determines that the benefits no longer outweigh the risks of the device and that the health or safety of Canadian patients, users or any other person may be unduly affected;
- Health Canada determines that the terms and conditions imposed are not met;
- A medical device licence is issued for the COVID-19 medical device under section 36 of the Regulations; or
- The authorization for sale of a COVID-19 medical device that has been issued by a foreign regulatory authority is suspended or cancelled.
An authorization for importation or sale under the Interim Order is subject to compliance and enforcement should Health Canada be made aware of issues of noncompliance.
Additional Information and Material
Health Canada may, at any time, request additional information or material (including samples) from the applicant in order to ensure that the provisions under section 5 of the Interim Order continue to be met. This information will be used to determine whether Health Canada will move forward with the issuance, amendment or cancellation of the COVID-19 medical device authorization.
For the express purpose of expediting access to COVID-19 medical devices to the Canadian market, Health Canada will accept labelling in either English or French at the time of application. However, any medical device authorized under the provisions of the Interim Order should make bilingual labelling available as soon as possible, and upon request, by the purchaser. Specific to devices that are intended to be sold to the general public, bilingual labelling should be available to the purchaser at the time of purchase, either directly on the packaging or physically accompanying the device.
The following information will be required on the label:
a) The name of the device;
Each device including a system, medical device group, medical device family, or medical device group family must have a name. The device licence is issued for (a) the device name on the label which may describe one device, (b) an administrative grouping of devices sold for convenience under a single name or (c) a grouping of devices that carry the same generic name specifying the intended use of the devices. This name permits the user to identify it and distinguish it from other devices or device types.
b) The name and address of the manufacturer;
If more than one name appears on the label, the relationship of each name to the device must be made clear, such as in the case of private labelling agreements between the manufacturer and the distributor or importer. The device licence is issued to the manufacturer named on the label.
c) The identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;
The identifier is a unique number assigned to the device by the manufacturer, which along with the name of the device, will permit a device to be distinguished from all other devices. It may be a catalogue number, model number, or a barcode and will permit, in combination with the name, a certain level of control and traceability in the market place.
d) In the case of a Class III or IV device, the control number;
The control number means a unique series of letters, numbers or symbols, or any combination of these, that is assigned to a COVID-19 medical device by the manufacturer and, from which the history of the manufacturing, packaging, labelling or distribution of a unit, lot or batch of finished devices can be determined. The control number allows the device to be traced from manufacture to the end user, including an individual in whom the device may have been implanted. Along with the name of the device and the identifier, it provides the highest degree of traceability.
This is a requirement for Class III and Class IV devices only. Although not mandatory for Class I and Class II devices, the control number enhances postmarket traceability.
(e) If the contents are not readily apparent, an indication of what the package contains, expressed in terms appropriate to the device, such as the size, net weight, length, volume or number of units;
The intent of this requirement is to provide specific information describing the package contents to the user and to enable the user to make an informed choice when comparing similar devices. The information will also allow the user to select a size suitable for his/her purposes. Units should be expressed in metric or SI units (International System of Units). When applicable, the material used in the device should be specified.
f) If the device is sterilized by the manufacter and the manufacturer intends for it to be sold in a sterile condition, then this must be indicated on the label.
g) The expiry date of the device, if the device has one. This is to be determined by the manufacturer on the basis of the component that has the shortest projected useful life;
The life of the least stable component determines the expiration date. The expiration date must be based on the results of studies which demonstrate that the device will perform as intended and will meet its specifications until that date. The date should be expressed in the internationally accepted format (ISO 8601 Data Elements and Interchange Formats-Information Exchange-Representation of Dates and Times): year (in four digits), month (in two digits), and day (in two digits). The separator for the three portions of the date should be a hyphen (-).
h) Unless self-evident to the intended user, the medical conditions, purposes and uses for which the device is manufactured, sold or represented, as well as the performance specifications of the device if those specifications are necessary for proper use;
This section requires the manufacturer to state succinctly what the device is intended to do and on which population subgroup the device is intended to be used, for example, "For use in adults over 18 years of age." The purposes and uses refer to the function of the device as well as to the objective intent of the manufacturer. This intent may be communicated by the labelling claims, advertising, or written or oral statements made by the manufacturer or representatives.
There are some devices that may be sold to the general public, and which often have an intended use that is self-evident to the user, for which such labelling may not be necessary (e.g. gloves).
i) The directions for use, unless directions are not required, for the device to be used safely and effectively;
This is the information supplied to the lay person and/or the health care professional enabling them to use the device without causing unnecessary harm to themselves or another person and to achieve the desired result. The Directions for use should be written at a level commensurate with the training of the expected users.
For some complex, diagnostic, active or powered devices, the Directions for use may require a special Surgeon's Instruction Manual, Operator's Manual, and a User's Manual.
There are some devices that may not require directions for use to be provided, as the ability to use the device is inherent in its' design (e.g. gloves).
j) Any special storage conditions applicable to the device.
Some devices may deteriorate rapidly under certain environmental conditions as they relate to temperature, humidity, or light, and may need to be stored in a specified manner to prevent this deterioration. The user must be provided with this information in order to decide if such storage conditions are accessible or within their means. Storage temperatures should be provided in degrees Celsius.
Importers and distributors do not require Medical Device Establishment Licences (MDELs) to import and sell COVID-19 medical devices that have been granted authorization under the Interim Order. Each shipment of a COVID-19 medical device that is imported into Canada must be accompanied by a copy of the Interim Order authorization. This document will be issued to the applicant upon authorization and will facilitate transport of the COVID-19 medical device(s) across the border, as it will be used as a signal that the device has been authorized under this Interim Order. Importers should rely on this mechanism to demonstrate to Health Canada that a shipment containing COVID-19 medical device should be allowed access into Canada.
The holder of the COVID-19 medical device authorization for the importation or sale of the device is to report to Health Canada within 10 days of becoming aware, all Canadian incidents that:
- Are related to a failure of device or a deterioration in its quality or effectiveness, or any inadequacy in its labelling or in its directions for use; or
- Have led to the death or a serious deterioration in the state of health of a patient, user or other person, or could do so were it to recur.
A description, the frequency and the circumstances surrounding the incident is also to be provided as part of the report. The description of each type of problem should be clear and any remedial or corrective actions undertaken should be explained. The submission should clearly state that the device was approved under the Interim Order, and provide the Interim Order authorization number in lieu of a medical device license number.
The incident report can be submitted according to the procedure outlined in the following website:
It is expected that the authorization holder submit a preliminary report to Health Canada within 10 days, followed by a final report once investigation is completed.
Sections 13-15 of the Interim Order allow the Minister to grant an expanded indication for use or intended use, to include COVID-19 related diagnostic, treatment, mitigation or prevention claims based on known evidence. This expansion may be applied to COVID-19 medical devices authorized under this Interim Order, or to medical devices licensed under the Medical Devices Regulations.
When the Minister decides to issue an expanded use indication, it will make information publically available, related to the device approved and the new indication. This will then be published to the List of Medical Devices for Expanded Use in Relation to COVID-19 Pandemic that is published by the Government of Canada on its website. Additionally, if the Minister believes that a medical device authorization holder has any information in relation to the proposed expanded use of the licensed medical device or the COVID-19 medical device, the Minister may request that information and the authorization holder must provide it.
While the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 does not have unique requirements related to recall, it is important to clarify that any device authorized under this Interim Order is subject to Mandatory Recall provisions under The Food and Drugs Act. In addition, while the ability for the Minister to order a mandatory recall is still available, manufacturers should proactively notify Health Canada if they become aware of the need to recall their COVID-19 medical device in Canada. The following link provides guidance on to how to conduct a recall in Canada: Guide to Recall of Medical Devices (GUI-0054).
Service standards for interim order applications for COVID-19 medical devices
An interim order for importing and selling medical devices for use against COVID-19 took effect on March 18, 2020. Medical devices related to this interim order (IO) are captured in the:
- list of authorized testing devices
- list of authorized medical devices other than testing devices
- list of applications (for testing devices) under evaluation
Before applying for an IO authorization or before contacting Health Canada for help, companies should first review the guidance document for this IO. Please review especially the section on "submitting an application for a COVID-19 medical device." Knowing what is involved before you apply will help ensure your application:
- is of good quality
- will be processed quickly
- prioritize the review of applications for COVID-19 devices that meet a Canadian public health need, using existing priority review criteria
- reject applications that are incomplete
- this excludes minor requests seeking more information or clarification
- refuse applications that lack the evidence needed to complete a review or where manufacturers haven't adequately responded to our request for more information
The following service standards apply to all COVID-19 IO applicationsFootnote *.
Initial screening stage
Health Canada screens the application to ensure it includes all the necessary information.Class I, II, III and IV: 15 calendar days from submission.
To note: Within 15 days of submission, Health Canada will either ask for more information or indicate the application is complete. If we do not receive a response to a request for more information within 10 calendar days, we will consider the applicant has withdrawn its IO application.
If Health Canada considers the IO application is complete, the application passes to the review stage.
Health Canada does a scientific assessment of the application.
Class I and II: 25 calendar days from acceptance of a complete application.
Class III and IV: 40 calendar days from acceptance of a complete application.
To note: Health Canada will either ask for more information or issue a final decision (refusal or authorization).
- Footnote *
With the exception of priority files mentioned above, Health Canada will process files in the order in which they are received. In the case of files received before the publication of this notice, the service standard would apply from the date of publication of this notice, not the date of receipt of the application.
Appendix A: Application form
Appendix B: Attestation form (example)
Under 4(1)(i) of the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19, an applicant is required to attest to the availability of documented procedures for certain activities. Check () the relevant attestation.
[ ] I, the Applicant, have objective evidence to establish that I have documented procedures in place with respect to distribution records, complaint handling, incident reporting and recalls. I submit this attestation in partial fulfillment of the application submission requirements of the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19.
I, as a senior official of the manufacturer of this application, hereby attest that I have direct knowledge of the item checked above and declare that these identified statements are true and that the information provided in this application and in any attached documentation is accurate and complete.
Where a person is named in Item X of this application, I hereby authorize that person to submit this application to the Minister on my behalf. I further authorize the Medical Devices Directorate to direct all correspondence relating to this application to the person named in Item X of this application.
Report a problem or mistake on this page
- Date modified: